NP Life Sciences Health Industry Group
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NP Life Sciences Health Industry Group generated cash of $93,873, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $93,873.

Cash Flow

NP Life Sciences Health Industry Group Inc. (OTC:GJCU): Cash Flow
2018 0 0 200
2019 -113.09K -8.6K 364.42K
2020 -124.32K 0 0
2021 -90.62K 0 0
2022 93.87K 0 0

GJCU Cash Flow Statement (2018 – 2022)

2022 2021 2020 2019 2018
Cash at beginning of period
27.98K118.61K242.93K2000
Operating activities
Net income
-18.85K4-131.06K-108.82K-20.89K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
001.56K1.43K0
Stock-based compensation expense
00000
Deferred income tax benefit 00000
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
6.13K0-1.03K5650
Cash generated by operating activities
93.87K-90.62K-124.32K-113.09K0
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
000-8.6K0
Acquisitions Net
00000
Cash generated by investing activities
000-8.6K0
Financing activities
Common Stock Issued
000364.42K0
Payments for dividends
00000
Repurchases of common stock
0000200
Repayments of term debt
00000
Cash used in financing activities
000364.42K200
Net Change In Cash
93.87K-90.62K-124.32K242.73K200
Cash at end of period
121.85K27.98K118.61K242.93K200
Data sourceData sourceData sourceData source